Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · October 30, 2014

Bimatoprost Solution 0.03% for Treatment of Hypotrichosis

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomised Controlled Trial
Br J Dermatol 2014 Oct 09;[EPub Ahead of Print], DA Glaser, P Hossain, W Perkins, T Griffiths, G Ahluwalia, E Weng, FC Beddingfield

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading